What is Chemical Works of Gedeon Richter Current Ratio?
Chemical Works of Gedeon RichterRGEDF -1.78%94 Current Ratio is 4.37 as of Dec. 2025, which is 17% above its 10-year median of 3.75. GuruFocus rates RGEDF with a GF Score™ of 94/100 and a GF Value™ of $35.22 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 998 Drug Manufacturers companies, Chemical Works of Gedeon Richter ranks better than 81.66% on this metric.
Chemical Works of Gedeon Richter has a current ratio of 4.37. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Chemical Works of Gedeon Richter's Current Ratio or its related term are showing as below:
RGEDF'
s Current Ratio Range Over the Past 10 Years
Min: 3.21 Med: 3.75 Max: 4.67
Current: 4.37
During the past 13 years, Chemical Works of Gedeon Richter's highest Current Ratio was 4.67. The lowest was 3.21. And the median was 3.75.
RGEDF's Current Ratio is ranked better than 81.66% of 998
companies
in the Drug Manufacturers industry
Industry Median: 1.995
vs RGEDF: 4.37
Chemical Works of Gedeon Richter (OTCPK:RGEDF) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Chemical Works of Gedeon Richter Current Ratio Related Terms
Chemical Works of Gedeon Richter Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chemical Works of Gedeon Richter Current Ratio Chart
RGEDF vs ZTS, UTHR, VTRS: Current Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Chemical Works of Gedeon Richter's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chemical Works of Gedeon Richter Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Chemical Works of Gedeon Richter's Current Ratio distribution charts can be found below:
* The bar in red indicates where Chemical Works of Gedeon Richter's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chemical Works of Gedeon Richter (RGEDF) has a Current Ratio of 4.37 as of Dec. 2025. This is 17% above median its historical median of 3.75. Over the past decade, Chemical Works of Gedeon Richter's Current Ratio has ranged from 3.21 to 4.67. According to the industry distribution chart, Chemical Works of Gedeon Richter ranks #183 out of 998 companies in the Drug Manufacturers industry, placing it in the top 18.3%.
Is Chemical Works of Gedeon Richter's Current Ratio too high?
Chemical Works of Gedeon Richter's current Current Ratio of 4.37 is 17% above median its 10-year median of 3.75. Over the past 10 years, this metric has ranged from a low of 3.21 to a high of 4.67. The Drug Manufacturers industry median Current Ratio is 2.00. Chemical Works of Gedeon Richter's value of 4.37 is 119% above this industry median. Based on the distribution chart, Chemical Works of Gedeon Richter ranks #183 out of 998 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Chemical Works of Gedeon Richter has a GF Score™ of 94/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Chemical Works of Gedeon Richter's Current Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Chemical Works of Gedeon Richter ranks #183 out of 998 companies for Current Ratio. This places Chemical Works of Gedeon Richter in the top 18% of its industry — outperforming the majority of peers. The industry median Current Ratio is 2.00. Chemical Works of Gedeon Richter's value of 4.37 is 119% above this benchmark. Historically, Chemical Works of Gedeon Richter's own Current Ratio has ranged from 3.21 to 4.67 over the past decade. While the company's 10-year median is 3.75 vs. the industry median of 2.00, Chemical Works of Gedeon Richter has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 998 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chemical Works of Gedeon Richter's current Current Ratio of 4.37 is 119% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chemical Works of Gedeon Richter's current Current Ratio is 4.37, which is 17% above median its own 10-year median of 3.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemical Works of Gedeon Richter stock overvalued right now?
Based on GuruFocus' analysis, Chemical Works of Gedeon Richter (RGEDF) is currently considered Modestly Overvalued. The stock's GF Value™ is $35.22, compared to a current price of $39.59 — trading 12.4% above its estimated fair value. The current Current Ratio is 4.37, which is 17% above median its 10-year median of 3.75 and 119% above the Drug Manufacturers industry median of 2.00. Chemical Works of Gedeon Richter's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Chemical Works of Gedeon Richter (RGEDF), the current Current Ratio is 4.37 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chemical Works of Gedeon Richter (RGEDF) Overvalued in 2026?
Based on GuruFocus' analysis, Chemical Works of Gedeon Richter stock appears to be overvalued.
The current stock price of $39.59 is trading 12.4% above its estimated GF Value™ of $35.22.
GuruFocus considers Chemical Works of Gedeon Richter to be Modestly Overvalued.
Key valuation signals for RGEDF:
Current Ratio: 4.37 (17% above median its 10-year median of 3.75)
GF Value™: $35.22 vs. price of $39.59 (12.4% above fair value)
Industry Position: 119% above the Drug Manufacturers median (#183 of 998)
No single metric tells the full story. See the RGEDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chemical Works of Gedeon Richter Business Description
Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular, and central nervous system products. It manufactures medicines including original, generic and licensed products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharma segment comprising Women's Healthcare, Neuropsychiatry, Biotechnology, General Medicine, and Other pharma; and the Others segment includes the remaining wholesale and retail business of the Group and all other activities. The company operates internationally.
94GF Score
Get the complete analysis for RGEDF
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RGEDF has been successfully added to your 
